| Absorption |
| Blood-Brain Barrier | BBB+ | 0.7144 |
| Human Intestinal Absorption | HIA+ | 0.9418 |
| Caco-2 Permeability | Caco2- | 0.5855 |
| P-glycoprotein Substrate | Non-substrate | 0.7351 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9791 |
| Non-inhibitor | 0.9252 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8989 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8504 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8418 |
| CYP450 2D6 Substrate | Non-substrate | 0.8931 |
| CYP450 3A4 Substrate | Non-substrate | 0.7786 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9088 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9043 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9707 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9622 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9543 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9759 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9462 |
| Non-inhibitor | 0.9276 |
| AMES Toxicity | Non AMES toxic | 0.9486 |
| Carcinogens | Non-carcinogens | 0.7964 |
| Fish Toxicity | Low FHMT | 0.5099 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.7251 |
| Honey Bee Toxicity | High HBT | 0.6594 |
| Biodegradation | Ready biodegradable | 0.9364 |
| Acute Oral Toxicity | III | 0.5988 |
| Carcinogenicity (Three-class) | Non-required | 0.7159 |